Eastman Chemical (EMN) Cost of Revenue (2009 - 2026)

Eastman Chemical (EMN) has 18 years of Cost of Revenue data on file, last reported at $1.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 1.33% year-over-year to $1.7 billion; the trailing twelve-month figure through Mar 2026 stood at $6.9 billion (down 1.51% YoY), and the FY2025 full-year result was $6.9 billion, down 2.59% from the prior year.
• Cost of Revenue for Q1 2026 stood at $1.7 billion, up from $1.6 billion in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.2 billion in Q3 2022 and bottomed at $1.6 billion in Q4 2025.
• The 5-year median for Cost of Revenue is $1.8 billion (2024), against an average of $1.8 billion.
• The widest annual swing landed in 2022, when Cost of Revenue rose 19.49%; it then slipped 17.76% in 2023.
• A 5-year view of Cost of Revenue shows it stood at $2.0 billion in 2022, then retreated by 12.72% to $1.7 billion in 2023, then fell by 2.98% to $1.7 billion in 2024, then decreased by 3.31% to $1.6 billion in 2025, then advanced by 6.79% to $1.7 billion in 2026.
• The last three Cost of Revenue figures came in at $1.7 billion (Q1 2026), $1.6 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.

Peer Comparison